Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$84.67 USD
-1.28 (-1.49%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $84.65 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Bottom 46% (136 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.16 | 1.57 | 9.99 |
Current Quarter Estimate | 0.70 | 3.93 | 60.00 |
Year Ago Quarter Estimate | 0.66 | 3.85 | 52.54 |
Next Quarter Estimate | 0.69 | 3.92 | 61.00 |
Next Year Estimate | 3.11 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.36 | 14.40 | 17.08 |
Next Year | 12.27 | 22.40 | 8.00 |
Last 5 Years | 9.90 | 10.00 | 8.10 |
Next 5 Years | 8.60 | 14.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 33.71 | 29.13 |
Price/Book (MRQ) | 7.20 | 2.35 |
Price/Cash Flow (MRFY) | 31.11 | 15.02 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 23.01% | 11.04% |
Return on Equity (TTM) | 22.86% | 12.91% |
Debt to Equity (MRQ) | 0.08 | 12.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.